Companies you'll love to work for

Engrail Therapeutics

engrail.com

Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019, focused on developing innovative, precision-targeted therapeutics for neuropsychiatric and neurodevelopmental disorders. The company aims to become a leader in neuroscience by addressing the needs of patients with devastating conditions through a strong pipeline built on partnerships and internal discovery capabilities. Engrail's commitment to rapid advancement of its therapies positions it uniquely in the market, leveraging scientific expertise in molecular mechanisms and neurocircuitry to deliver transformational therapies.